<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03796091</url>
  </required_header>
  <id_info>
    <org_study_id>1516-105-GRE</org_study_id>
    <secondary_id>R15MH113044</secondary_id>
    <nct_id>NCT03796091</nct_id>
  </id_info>
  <brief_title>Efficacy Trial of a Dissonance Based Eating Disorder Program</brief_title>
  <official_title>Efficacy Trial of a Dissonance Based Eating Disorder Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cornell College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Cornell College</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to investigate whether symptoms of disordered eating&#xD;
      change among participants who complete an intervention. Participants will be randomly&#xD;
      assigned to one of three intervention conditions and will undergo assessments of symptoms&#xD;
      before, after, and 2 months after each intervention. Investigators are evaluating which&#xD;
      interventions are most effective in reducing eating disorder symptoms and disorder-related&#xD;
      psychological and cardiac risk factors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assessment Sessions (Preintervention, Postintervention, 2-month follow-up): Participants in&#xD;
      all conditions will participate in a series of 3 assessment sessions. Prior to each session,&#xD;
      participants will complete online questions assessing eating disorder symptoms and associated&#xD;
      psychological risk factors. This process will take approximately 40 minutes. Next&#xD;
      participants will report to the laboratory at their scheduled appointment time to have their&#xD;
      cardiac function assessed via blood pressure measurements and electrocardiography (EKG or&#xD;
      ECG). Participants' height and weight will also be recorded.&#xD;
&#xD;
      Prior to each assessment session, participants should:&#xD;
&#xD;
        -  Complete the online survey (if not completed prior to each laboratory appointment this&#xD;
           will need to be completed at the lab appointment)&#xD;
&#xD;
        -  Fast (not consume any food or beverages other than water) for at least 3 hours.&#xD;
&#xD;
        -  Refrain from using nicotine for at least 3 hours.&#xD;
&#xD;
        -  Refrain from vigorous physical exercise for at least 24 hours.&#xD;
&#xD;
        -  Not show any symptoms of acute physical illness for 48 hours. It is important for&#xD;
           participants to follow these directions so researchers can gather the most accurate&#xD;
           data. If participants forget to follow these guidelines, or if an illness occurs,&#xD;
           participants should contact their experimenter to reschedule.&#xD;
&#xD;
      On the day of an assessment session, participants will drive to the assessment location.&#xD;
      Participants will receive directions via e-mail prior to each session. During the assessment&#xD;
      session, participants will lie down on a laboratory cot for 10 minutes while preparation for&#xD;
      electrocardiography (EKG or ECG) occurs. Electrodes will be applied to the chest and torso&#xD;
      and lead wires will be attached to the electrodes. Participants' blood pressure will be&#xD;
      assessed several times throughout this interval. Next, the experimenter will collect a 5&#xD;
      minute and 30 second recording of participants' cardiovascular data via electrocardiography&#xD;
      (ECG or EKG). This data will later be analyzed to examine cardiac function.Next experimenters&#xD;
      will assess participants' height and weight.&#xD;
&#xD;
      After each assessment session, participants' eating disorder symptoms, psychological risk&#xD;
      factors, and cardiac indices will be evaluated by the research team. If the team determines&#xD;
      that symptoms or cardiac indices are atypical and indicate a further need for evaluation, the&#xD;
      participant will be contacted via both e-mail and phone to be informed results are atypical&#xD;
      and the participant will be referred for further evaluation by a medical provider. If the&#xD;
      participant is a minor, this information will be provided both to the participant and to the&#xD;
      participant's parent and/or the participant's legal guardian. If participants' symptoms or&#xD;
      risk factors worsen significantly over the duration of the trial, participants will also be&#xD;
      contacted and provided with referral recommendations.&#xD;
&#xD;
      All participants will receive a comprehensive symptom report at the end of the trial.&#xD;
      Referral resources will be provided again at that time if significant eating disorder&#xD;
      symptoms remain.&#xD;
&#xD;
      Treatment Conditions: Participants will be randomly assigned to 1 of 3 treatment conditions.&#xD;
&#xD;
      Brochure Treatment Condition: Participants randomly assigned to the educational brochure will&#xD;
      receive two educational brochures which discuss eating disorder symptoms. The brochures will&#xD;
      also include treatment referral information and recommended resources for persons struggling&#xD;
      with disordered eating. The brochure will take approximately 10 minutes to read; follow-up&#xD;
      with treatment or self-help referral resources is completely voluntary.&#xD;
&#xD;
      Group Therapy Treatment Conditions: Participants randomly assigned to one of the two group&#xD;
      treatment intervention conditions will complete a 4-week group treatment program with 3-8&#xD;
      other women and 2 trained treatment co-facilitators. For approximately 1 hour each week,&#xD;
      participants will meet in this group to complete a series of readings, written activities,&#xD;
      and verbal activities designed to reduce disordered eating. During the 4 intervention&#xD;
      sessions, participants will be asked to analyze the weight and appearance-related messages&#xD;
      received from the media, peers, family, romantic partners, and other sources. Participants&#xD;
      will also be asked to record, analyze, and evaluate weight and appearance-related thoughts,&#xD;
      emotions, and behaviors. Participants will engage in a variety of exercises designed to&#xD;
      evaluate the meaning of thinness in our culture and its personal impact. These exercises are&#xD;
      designed to combat the detrimental impact of messages which promote thinness.&#xD;
&#xD;
      Other risk factors will also be addressed, depending upon program. Participants may talk&#xD;
      about the pressures women receive to focus on appearance. The relationship between these&#xD;
      appearance-related pressures and eating disorder symptoms will be explored. Participants will&#xD;
      explore the way they compare themselves to others and participate in a series of discussions&#xD;
      and activities designed to decrease appearance-based comparisons with others.&#xD;
&#xD;
      After the 4-week program is complete, participants in both intervention conditions will&#xD;
      continue to work on homework assignments related to the program for a period of 2-months&#xD;
      until the final assessment session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 18, 2018</start_date>
  <completion_date type="Actual">April 15, 2021</completion_date>
  <primary_completion_date type="Actual">April 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, controlled clinical trial with 3 treatment interventions</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rosenberg Self-Esteem Scale (RSE).</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rosenberg Self-Esteem Scale (RSE).</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rosenberg Self-Esteem Scale (RSE).</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eating Disorder Examination Questionnaire (EDE-Q).</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eating Disorder Examination Questionnaire (EDE-Q).</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eating Disorder Examination Questionnaire (EDE-Q).</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Shape Questionnaire (BSQ).</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Shape Questionnaire (BSQ).</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Shape Questionnaire (BSQ).</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Comparison Rating Scale (SCRS).</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Comparison Rating Scale (SCRS).</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Comparison Rating Scale (SCRS).</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-Objectification Questionnaire (SOQ)</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-Objectification Questionnaire (SOQ)</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-Objectification Questionnaire (SOQ)</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ideal Body Stereotype Scale - Revised.</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ideal Body Stereotype Scale - Revised.</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ideal Body Stereotype Scale - Revised.</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory - Form Y.</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory - Form Y.</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory - Form Y.</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Positive Affect</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Positive Affect</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Positive Affect</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean R Wave Amplitude</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean R Wave Amplitude</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean R Wave Amplitude</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>QT Interval Length</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>QT Interval Length</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>QT Interval Length</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vagal Cardiac Tone - High Frequency Spectral Power</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vagal Cardiac Tone - High Frequency Spectral Power</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vagal Cardiac Tone - High Frequency Spectral Power</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Negative Affect</measure>
    <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Negative Affect</measure>
    <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive and Negative Affect Scale - Negative Affect</measure>
    <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
    <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Eating Disorder</condition>
  <arm_group>
    <arm_group_label>Educational Brochure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Body Project Traditional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Body Project Expanded</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational Brochure</intervention_name>
    <description>Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
    <arm_group_label>Educational Brochure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Body Project Traditional</intervention_name>
    <description>Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
    <arm_group_label>Body Project Traditional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Body Project Expanded</intervention_name>
    <description>Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
    <arm_group_label>Body Project Expanded</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion Criteria&#xD;
&#xD;
               -  Women&#xD;
&#xD;
               -  Age 15-34&#xD;
&#xD;
               -  Postmenarcheal&#xD;
&#xD;
               -  Premenopausal&#xD;
&#xD;
               -  Subclinical or Clinical Eating Disorder Symptoms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion Criteria&#xD;
&#xD;
               -  Must get physician clearance to participate if at medically high risk as defined&#xD;
                  in the protocol&#xD;
&#xD;
               -  Must not be pregnant&#xD;
&#xD;
               -  Must be able to read and speak English&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melinda A Green, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Green Counseling Services PLLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cornell College Eating Disorder Institute</name>
      <address>
        <city>Mount Vernon</city>
        <state>Iowa</state>
        <zip>52314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>December 31, 2018</study_first_submitted>
  <study_first_submitted_qc>January 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2019</study_first_posted>
  <results_first_submitted>July 24, 2022</results_first_submitted>
  <results_first_submitted_qc>November 13, 2022</results_first_submitted_qc>
  <results_first_posted type="Actual">December 9, 2022</results_first_posted>
  <last_update_submitted>November 13, 2022</last_update_submitted>
  <last_update_submitted_qc>November 13, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cornell College</investigator_affiliation>
    <investigator_full_name>Dr. Melinda Green</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Feeding and Eating Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available to other researchers upon request and subject to signed confidentiality agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Upon request with 5 years of study completion.</ipd_time_frame>
    <ipd_access_criteria>Must sign confidentiality agreement.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT03796091/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT03796091/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT03796091/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Women aged 15-35 displaying subclinical and clinical eating disorder symptoms were recruited from 2 Midwestern cities and 5 surrounding suburban communities from November of 2018 to March of 2021. All participants were treated in accordance with federal guidelines (Title 45, Code of Regulations Part 46) for the treatment of human participants. The research was approved by an Institutional Review Board at the host institution.</recruitment_details>
      <pre_assignment_details>All participants were screened to ensure inclusion criteria were met. Inclusion criteria specified female participants ages 15-34 (postmenarcheal and premenopausal) who were not pregnant. Participant selection was limited to this group to control for the effects of estrogen on cardiac function and in accordance with previous research which suggests dissonance-based programs are most effective when offered solely to females over the age of 15.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Educational Brochure</title>
          <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
        </group>
        <group group_id="P2">
          <title>Body Project Traditional</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
        </group>
        <group group_id="P3">
          <title>Body Project Expanded</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The numbers presented in the Baseline Analysis Population indicate the number of participants as a function of condition who completed the baseline assessment session. This differs from the number of participants in the Participant Flow Module because that module reflects the number of participants who completed the pre-trial screening and were enrolled in the trial. The discrepancy is explained by participants not attending the baseline assessment following study enrollment at screening.</population>
      <group_list>
        <group group_id="B1">
          <title>Educational Brochure</title>
          <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
        </group>
        <group group_id="B2">
          <title>Body Project Traditional</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
        </group>
        <group group_id="B3">
          <title>Body Project Expanded</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="50"/>
            <count group_id="B4" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.48" spread="3.63"/>
                    <measurement group_id="B2" value="23.95" spread="5.73"/>
                    <measurement group_id="B3" value="21.73" spread="4.08"/>
                    <measurement group_id="B4" value="22.75" spread="4.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="150"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="122"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Rosenberg Self-Esteem Scale</title>
          <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.71" spread="4.71"/>
                    <measurement group_id="B2" value="22.50" spread="4.81"/>
                    <measurement group_id="B3" value="22.62" spread="4.07"/>
                    <measurement group_id="B4" value="22.61" spread="4.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Eating Disorder Examination Questionnaire</title>
          <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.25" spread="0.8"/>
                    <measurement group_id="B2" value="3.93" spread="1.15"/>
                    <measurement group_id="B3" value="3.96" spread="1.02"/>
                    <measurement group_id="B4" value="4.04" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Shape Questionnaire</title>
          <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="139.42" spread="23.92"/>
                    <measurement group_id="B2" value="134.37" spread="30.15"/>
                    <measurement group_id="B3" value="134.73" spread="28.32"/>
                    <measurement group_id="B4" value="136.17" spread="27.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Social Comparison Rating Scale</title>
          <description>The Social Comparison Rating Scale (SCRS is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.59" spread="17.10"/>
                    <measurement group_id="B2" value="43.83" spread="13.18"/>
                    <measurement group_id="B3" value="43.00" spread="13.80"/>
                    <measurement group_id="B4" value="44.15" spread="14.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Self-Objectification Questionnaire</title>
          <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.13" spread="9.75"/>
                    <measurement group_id="B2" value="7.71" spread="13.11"/>
                    <measurement group_id="B3" value="6.32" spread="12.46"/>
                    <measurement group_id="B4" value="8.07" spread="11.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ideal Body Stereotype Scale Revised</title>
          <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.81" spread="0.5"/>
                    <measurement group_id="B2" value="3.82" spread=".45"/>
                    <measurement group_id="B3" value="3.76" spread="0.5"/>
                    <measurement group_id="B4" value="3.79" spread=".48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>State Trait Anxiety Inventory Form Y</title>
          <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.87" spread="8.42"/>
                    <measurement group_id="B2" value="58.02" spread="7.84"/>
                    <measurement group_id="B3" value="58.70" spread="7.90"/>
                    <measurement group_id="B4" value="58.52" spread="7.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Positive and Negative Affect Scale - Positive Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.35" spread="5.76"/>
                    <measurement group_id="B2" value="25.53" spread="7.10"/>
                    <measurement group_id="B3" value="25.24" spread="6.46"/>
                    <measurement group_id="B4" value="25.71" spread="6.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean R Wave Amplitude</title>
          <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection.</description>
          <units>mV</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.27" spread=".36"/>
                    <measurement group_id="B2" value="1.19" spread=".31"/>
                    <measurement group_id="B3" value="1.24" spread=".37"/>
                    <measurement group_id="B4" value="1.23" spread=".35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>QTc Prolongation</title>
          <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula.</description>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".38" spread=".02"/>
                    <measurement group_id="B2" value=".38" spread=".02"/>
                    <measurement group_id="B3" value=".38" spread=".02"/>
                    <measurement group_id="B4" value=".38" spread=".02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Positive and Negative Affect Scale - Negative Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.15" spread="7.46"/>
                    <measurement group_id="B2" value="29.00" spread="6.88"/>
                    <measurement group_id="B3" value="29.64" spread="6.60"/>
                    <measurement group_id="B4" value="29.59" spread="6.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
          <description>Vagal tone was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz.</description>
          <units>Normalized units: HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.08" spread="19.56"/>
                    <measurement group_id="B2" value="57.26" spread="19.78"/>
                    <measurement group_id="B3" value="61.61" spread="5.87"/>
                    <measurement group_id="B4" value="58.51" spread="16.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sympathetic Cardiac Tone - Low Frequency/High Frequency Spectral Power Ratio</title>
          <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
          <units>ratio: LF (watts/HZ) / HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.02" spread="1.55"/>
                    <measurement group_id="B2" value=".99" spread=".84"/>
                    <measurement group_id="B3" value=".72" spread=".53"/>
                    <measurement group_id="B4" value=".91" spread="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rosenberg Self-Esteem Scale (RSE).</title>
        <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Rosenberg Self-Esteem Scale (RSE).</title>
          <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.71" spread="4.71"/>
                    <measurement group_id="O2" value="22.50" spread="4.81"/>
                    <measurement group_id="O3" value="22.62" spread="4.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Rosenberg Self-Esteem Scale (RSE).</title>
        <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Rosenberg Self-Esteem Scale (RSE).</title>
          <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.55" spread="4.30"/>
                    <measurement group_id="O2" value="25.45" spread="4.50"/>
                    <measurement group_id="O3" value="25.08" spread="4.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Rosenberg Self-Esteem Scale (RSE).</title>
        <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Rosenberg Self-Esteem Scale (RSE).</title>
          <description>The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. &quot;I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.55" spread="4.74"/>
                    <measurement group_id="O2" value="25.55" spread="4.09"/>
                    <measurement group_id="O3" value="26.60" spread="4.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
        <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
          <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.25" spread=".8"/>
                    <measurement group_id="O2" value="3.93" spread="1.15"/>
                    <measurement group_id="O3" value="3.96" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
        <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
          <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.17" spread=".64"/>
                    <measurement group_id="O2" value="2.93" spread="1.20"/>
                    <measurement group_id="O3" value="3.07" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
        <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Eating Disorder Examination Questionnaire (EDE-Q).</title>
          <description>The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.74" spread=".89"/>
                    <measurement group_id="O2" value="2.73" spread="1.20"/>
                    <measurement group_id="O3" value="2.78" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Body Shape Questionnaire (BSQ).</title>
        <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Body Shape Questionnaire (BSQ).</title>
          <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.42" spread="23.92"/>
                    <measurement group_id="O2" value="134.37" spread="30.15"/>
                    <measurement group_id="O3" value="134.73" spread="28.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Body Shape Questionnaire (BSQ).</title>
        <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Body Shape Questionnaire (BSQ).</title>
          <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.65" spread="20.91"/>
                    <measurement group_id="O2" value="110.96" spread="33.39"/>
                    <measurement group_id="O3" value="114.50" spread="30.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Body Shape Questionnaire (BSQ).</title>
        <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Body Shape Questionnaire (BSQ).</title>
          <description>The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.51" spread="23.74"/>
                    <measurement group_id="O2" value="105.19" spread="32.23"/>
                    <measurement group_id="O3" value="105.29" spread="28.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Social Comparison Rating Scale (SCRS).</title>
        <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Social Comparison Rating Scale (SCRS).</title>
          <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.59" spread="17.10"/>
                    <measurement group_id="O2" value="43.83" spread="13.18"/>
                    <measurement group_id="O3" value="43.00" spread="13.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Social Comparison Rating Scale (SCRS).</title>
        <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Social Comparison Rating Scale (SCRS).</title>
          <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.02" spread="16.34"/>
                    <measurement group_id="O2" value="51.09" spread="11.68"/>
                    <measurement group_id="O3" value="47.35" spread="14.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Social Comparison Rating Scale (SCRS).</title>
        <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Social Comparison Rating Scale (SCRS).</title>
          <description>The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.28" spread="17.39"/>
                    <measurement group_id="O2" value="53.39" spread="10.93"/>
                    <measurement group_id="O3" value="53.18" spread="15.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Self-Objectification Questionnaire (SOQ)</title>
        <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Self-Objectification Questionnaire (SOQ)</title>
          <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.13" spread="9.75"/>
                    <measurement group_id="O2" value="7.71" spread="13.11"/>
                    <measurement group_id="O3" value="6.32" spread="12.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Self-Objectification Questionnaire (SOQ)</title>
        <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Self-Objectification Questionnaire (SOQ)</title>
          <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.40" spread="9.08"/>
                    <measurement group_id="O2" value="6.70" spread="11.39"/>
                    <measurement group_id="O3" value="2.35" spread="13.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Self-Objectification Questionnaire (SOQ)</title>
        <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Self-Objectification Questionnaire (SOQ)</title>
          <description>The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.80" spread="8.34"/>
                    <measurement group_id="O2" value="2.81" spread="12.39"/>
                    <measurement group_id="O3" value="1.78" spread="12.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ideal Body Stereotype Scale - Revised.</title>
        <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Ideal Body Stereotype Scale - Revised.</title>
          <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.81" spread="0.5"/>
                    <measurement group_id="O2" value="3.82" spread=".45"/>
                    <measurement group_id="O3" value="3.76" spread=".5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ideal Body Stereotype Scale - Revised.</title>
        <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Ideal Body Stereotype Scale - Revised.</title>
          <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.76" spread="0.47"/>
                    <measurement group_id="O2" value="3.39" spread=".69"/>
                    <measurement group_id="O3" value="3.60" spread=".54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ideal Body Stereotype Scale - Revised.</title>
        <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Ideal Body Stereotype Scale - Revised.</title>
          <description>The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.76" spread=".52"/>
                    <measurement group_id="O2" value="3.34" spread=".59"/>
                    <measurement group_id="O3" value="3.46" spread=".40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>State Trait Anxiety Inventory - Form Y.</title>
        <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>State Trait Anxiety Inventory - Form Y.</title>
          <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.87" spread="8.42"/>
                    <measurement group_id="O2" value="58.02" spread="7.84"/>
                    <measurement group_id="O3" value="58.70" spread="7.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>State Trait Anxiety Inventory - Form Y.</title>
        <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>State Trait Anxiety Inventory - Form Y.</title>
          <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.15" spread="7.39"/>
                    <measurement group_id="O2" value="53.05" spread="8.22"/>
                    <measurement group_id="O3" value="54.63" spread="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>State Trait Anxiety Inventory - Form Y.</title>
        <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>State Trait Anxiety Inventory - Form Y.</title>
          <description>The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.63" spread="9.45"/>
                    <measurement group_id="O2" value="51.63" spread="7.00"/>
                    <measurement group_id="O3" value="52.58" spread="9.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Positive Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Positive Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.35" spread="5.76"/>
                    <measurement group_id="O2" value="25.53" spread="7.10"/>
                    <measurement group_id="O3" value="25.24" spread="6.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Positive Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Positive Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.54" spread="6.36"/>
                    <measurement group_id="O2" value="28.57" spread="5.64"/>
                    <measurement group_id="O3" value="27.82" spread="6.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Positive Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Positive Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.60" spread="6.44"/>
                    <measurement group_id="O2" value="27.84" spread="5.85"/>
                    <measurement group_id="O3" value="27.98" spread="5.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean R Wave Amplitude</title>
        <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Mean R Wave Amplitude</title>
          <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>millivolts (mV)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27" spread=".36"/>
                    <measurement group_id="O2" value="1.19" spread=".31"/>
                    <measurement group_id="O3" value="1.27" spread=".36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean R Wave Amplitude</title>
        <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Mean R Wave Amplitude</title>
          <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>millivolts (mV)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" spread=".32"/>
                    <measurement group_id="O2" value="1.19" spread=".24"/>
                    <measurement group_id="O3" value="1.27" spread=".36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean R Wave Amplitude</title>
        <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Mean R Wave Amplitude</title>
          <description>Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>millivolts (mV)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" spread=".31"/>
                    <measurement group_id="O2" value="1.14" spread=".26"/>
                    <measurement group_id="O3" value="1.12" spread=".26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>QT Interval Length</title>
        <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>QT Interval Length</title>
          <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".38" spread=".02"/>
                    <measurement group_id="O2" value=".38" spread=".02"/>
                    <measurement group_id="O3" value=".38" spread=".02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>QT Interval Length</title>
        <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>QT Interval Length</title>
          <description>QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".38" spread=".02"/>
                    <measurement group_id="O2" value=".39" spread=".01"/>
                    <measurement group_id="O3" value=".39" spread=".01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>QT Interval Length</title>
        <description>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>QT Interval Length</title>
          <description>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".38" spread=".02"/>
                    <measurement group_id="O2" value=".38" spread=".01"/>
                    <measurement group_id="O3" value=".38" spread=".01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
        <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
          <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>Normalized units: HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.08" spread="19.56"/>
                    <measurement group_id="O2" value="57.26" spread="19.78"/>
                    <measurement group_id="O3" value="61.61" spread="5.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
        <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
          <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>Normalized units: HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.15" spread="21.20"/>
                    <measurement group_id="O2" value="60.04" spread="23.46"/>
                    <measurement group_id="O3" value="60.58" spread="17.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
        <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Vagal Cardiac Tone - High Frequency Spectral Power</title>
          <description>High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>Normalized units: HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.65" spread="20.56"/>
                    <measurement group_id="O2" value="56.60" spread="22.83"/>
                    <measurement group_id="O3" value="58.81" spread="19.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
        <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
          <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>ratio: LF (watts/HZ) / HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" spread="1.55"/>
                    <measurement group_id="O2" value=".99" spread=".84"/>
                    <measurement group_id="O3" value=".72" spread=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
        <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
          <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>ratio: LF (watts/HZ) / HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" spread="3.51"/>
                    <measurement group_id="O2" value="1.05" spread="1.17"/>
                    <measurement group_id="O3" value=".85" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
        <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio</title>
          <description>Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>ratio: LF (watts/HZ) / HF (watts/Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="1.99"/>
                    <measurement group_id="O2" value="1.86" spread="4.64"/>
                    <measurement group_id="O3" value="1.32" spread="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Negative Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Baseline assessments occurred after screening and prior to the delivery of any interventions.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Negative Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.15" spread="7.46"/>
                    <measurement group_id="O2" value="29.00" spread="6.88"/>
                    <measurement group_id="O3" value="29.64" spread="6.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Negative Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Negative Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.63" spread="6.67"/>
                    <measurement group_id="O2" value="25.61" spread="6.99"/>
                    <measurement group_id="O3" value="25.59" spread="6.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive and Negative Affect Scale - Negative Affect</title>
        <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
        <time_frame>Follow-up assessments began approximately 8 weeks after the postintervention assessment.</time_frame>
        <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>Educational Brochure</title>
            <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
          </group>
          <group group_id="O2">
            <title>Body Project Traditional</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
          </group>
          <group group_id="O3">
            <title>Body Project Expanded</title>
            <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale - Negative Affect</title>
          <description>The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.</description>
          <population>Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.50" spread="7.96"/>
                    <measurement group_id="O2" value="24.24" spread="6.24"/>
                    <measurement group_id="O3" value="25.00" spread="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Information regarding adverse events were reported at baseline, postintervention (approximately 4 weeks after treatment initiation) and 2-month follow-up (approximately 8 weeks after treatment conclusion).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Educational Brochure</title>
          <description>Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.&#xD;
Educational Brochure: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.</description>
        </group>
        <group group_id="E2">
          <title>Body Project Traditional</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice &amp; Shaw, 2001).&#xD;
Body Project Traditional: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice &amp; Shaw, 2001).</description>
        </group>
        <group group_id="E3">
          <title>Body Project Expanded</title>
          <description>Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).&#xD;
Body Project Expanded: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <description>Hospitalization</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Melinda Green</name_or_title>
      <organization>Green Counseling Services PLLC</organization>
      <phone>5154508913</phone>
      <email>drgreen@greencounselingservice.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03796091
org study id: 1516-105-GRE
secondary id: R15MH113044
nct id: NCT03796091
lead sponsor: 
collaborator: 
has dmc: Yes
is fda regulated drug: No
is fda regulated device: No
The purpose of this clinical trial is to investigate whether symptoms of disordered eating
      change among participants who complete an intervention. Participants will be randomly
      assigned to one of three intervention conditions and will undergo assessments of symptoms
      before, after, and 2 months after each intervention. Investigators are evaluating which
      interventions are most effective in reducing eating disorder symptoms and disorder-related
      psychological and cardiac risk factors.
Assessment Sessions (Preintervention, Postintervention, 2-month follow-up): Participants in
      all conditions will participate in a series of 3 assessment sessions. Prior to each session,
      participants will complete online questions assessing eating disorder symptoms and associated
      psychological risk factors. This process will take approximately 40 minutes. Next
      participants will report to the laboratory at their scheduled appointment time to have their
      cardiac function assessed via blood pressure measurements and electrocardiography (EKG or
      ECG). Participants' height and weight will also be recorded.

      Prior to each assessment session, participants should:

        -  Complete the online survey (if not completed prior to each laboratory appointment this
           will need to be completed at the lab appointment)

        -  Fast (not consume any food or beverages other than water) for at least 3 hours.

        -  Refrain from using nicotine for at least 3 hours.

        -  Refrain from vigorous physical exercise for at least 24 hours.

        -  Not show any symptoms of acute physical illness for 48 hours. It is important for
           participants to follow these directions so researchers can gather the most accurate
           data. If participants forget to follow these guidelines, or if an illness occurs,
           participants should contact their experimenter to reschedule.

      On the day of an assessment session, participants will drive to the assessment location.
      Participants will receive directions via e-mail prior to each session. During the assessment
      session, participants will lie down on a laboratory cot for 10 minutes while preparation for
      electrocardiography (EKG or ECG) occurs. Electrodes will be applied to the chest and torso
      and lead wires will be attached to the electrodes. Participants' blood pressure will be
      assessed several times throughout this interval. Next, the experimenter will collect a 5
      minute and 30 second recording of participants' cardiovascular data via electrocardiography
      (ECG or EKG). This data will later be analyzed to examine cardiac function.Next experimenters
      will assess participants' height and weight.

      After each assessment session, participants' eating disorder symptoms, psychological risk
      factors, and cardiac indices will be evaluated by the research team. If the team determines
      that symptoms or cardiac indices are atypical and indicate a further need for evaluation, the
      participant will be contacted via both e-mail and phone to be informed results are atypical
      and the participant will be referred for further evaluation by a medical provider. If the
      participant is a minor, this information will be provided both to the participant and to the
      participant's parent and/or the participant's legal guardian. If participants' symptoms or
      risk factors worsen significantly over the duration of the trial, participants will also be
      contacted and provided with referral recommendations.

      All participants will receive a comprehensive symptom report at the end of the trial.
      Referral resources will be provided again at that time if significant eating disorder
      symptoms remain.

      Treatment Conditions: Participants will be randomly assigned to 1 of 3 treatment conditions.

      Brochure Treatment Condition: Participants randomly assigned to the educational brochure will
      receive two educational brochures which discuss eating disorder symptoms. The brochures will
      also include treatment referral information and recommended resources for persons struggling
      with disordered eating. The brochure will take approximately 10 minutes to read; follow-up
      with treatment or self-help referral resources is completely voluntary.

      Group Therapy Treatment Conditions: Participants randomly assigned to one of the two group
      treatment intervention conditions will complete a 4-week group treatment program with 3-8
      other women and 2 trained treatment co-facilitators. For approximately 1 hour each week,
      participants will meet in this group to complete a series of readings, written activities,
      and verbal activities designed to reduce disordered eating. During the 4 intervention
      sessions, participants will be asked to analyze the weight and appearance-related messages
      received from the media, peers, family, romantic partners, and other sources. Participants
      will also be asked to record, analyze, and evaluate weight and appearance-related thoughts,
      emotions, and behaviors. Participants will engage in a variety of exercises designed to
      evaluate the meaning of thinness in our culture and its personal impact. These exercises are
      designed to combat the detrimental impact of messages which promote thinness.

      Other risk factors will also be addressed, depending upon program. Participants may talk
      about the pressures women receive to focus on appearance. The relationship between these
      appearance-related pressures and eating disorder symptoms will be explored. Participants will
      explore the way they compare themselves to others and participate in a series of discussions
      and activities designed to decrease appearance-based comparisons with others.

      After the 4-week program is complete, participants in both intervention conditions will
      continue to work on homework assignments related to the program for a period of 2-months
      until the final assessment session.
allocation: Randomized
intervention model: Parallel Assignment
intervention model description: Randomized, controlled clinical trial with 3 treatment interventions
primary purpose: Treatment
masking: None (Open Label)
measure: Rosenberg Self-Esteem Scale (RSE).
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. "I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.
measure: Rosenberg Self-Esteem Scale (RSE).
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. "I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.
measure: Rosenberg Self-Esteem Scale (RSE).
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Rosenberg Self-Esteem Scale is designed to assess global feelings of self-worth. The RSE includes 10 items (e.g. "I feel that I'm a person of worth'') rated on a four-point scale (1 = strongly disagree, 4 = strongly agree). A total score represents the sum of individual item responses. Scores range from 10 to 40 and higher scores indicate higher levels of self-esteem.
measure: Eating Disorder Examination Questionnaire (EDE-Q).
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.
measure: Eating Disorder Examination Questionnaire (EDE-Q).
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.
measure: Eating Disorder Examination Questionnaire (EDE-Q).
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The 28-item Eating Disorder Examination Questionnaire global score was used to measure eating disorder symptomatology. Participants report symptomatology over the past 28 days on a 7-point Likert scale from 0 (no days) to 6 (everyday). The EDE-Q contains 4 subscales: Restraint, Weight Concern, Eating Concern, and Shape Concern. Subscale scores are calculated by finding the averages of the subscale items. A global score is also calculated by averaging the subscale scores. Scores range from 0 to 6; higher scores indicate higher levels of eating disorder pathology.
measure: Body Shape Questionnaire (BSQ).
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.
measure: Body Shape Questionnaire (BSQ).
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.
measure: Body Shape Questionnaire (BSQ).
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Body Shape Questionnaire (BSQ) was used to measure body dissatisfaction in the present trial. The BSQ is a 34-item scale. Items are measured on a 6-point Likert scale designed to assess the frequency of negative body-related thoughts (1= never, 6 = always). Individual items are summed to compute an overall score. Scores on this scale range from 34 to 204. Higher scores indicate higher frequency of negative body-related thoughts and higher levels of body dissatisfaction.
measure: Social Comparison Rating Scale (SCRS).
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.
measure: Social Comparison Rating Scale (SCRS).
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.
measure: Social Comparison Rating Scale (SCRS).
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Social Comparison Rating Scale (SCRS) is an 11-item scale used to assess perception of social rank and social comparison tendencies in the present trial. The scale consists of a series of bipolar adjectives (e.g., inferior/superior) separated by the numbers 1 through 10. For each adjective pair, participants are asked to rank themselves in comparison to others. A score around 60 indicates a person, on average, sees themselves approximately equal to others. Higher scores indicate higher levels of favorable social comparison and higher perceived social rank.
measure: Self-Objectification Questionnaire (SOQ)
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.
measure: Self-Objectification Questionnaire (SOQ)
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.
measure: Self-Objectification Questionnaire (SOQ)
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Self-Objectification Questionnaire (SOQ) is a 10-item self-report inventory designed to assess the relative importance of body competence versus body appearance in sense of self. Participants rank appearance- versus competence-based attributes from 0 to 9 with higher scores representing higher importance. An overall trait self-objectification score is computed by summing competence and appearance ratings and subtracting the sum of competence ratings from the sum of appearance ratings. Resulting scores range from -25 to 25. Higher scores denote higher levels of trait self-objectification.
measure: Ideal Body Stereotype Scale - Revised.
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.
measure: Ideal Body Stereotype Scale - Revised.
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.
measure: Ideal Body Stereotype Scale - Revised.
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Ideal Body Stereotype Scale - Revised was used to assess the extent to which participants internalized the cultural feminine thin-ideal. The IBSS-R is a self-report inventory which asks participants to report their level of agreement with 6 statements which indicate what attractive women look like on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). Responses are averaged to compute a total score. Scores ranges from 1 to 5; higher scores indicate higher levels of thin-ideal internalization.
measure: State Trait Anxiety Inventory - Form Y.
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.
measure: State Trait Anxiety Inventory - Form Y.
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.
measure: State Trait Anxiety Inventory - Form Y.
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The State Trait Anxiety Inventory- Form Y (STAI) is a 20-item self-report measure used to assess level of trait anxiety in the present study. Each item consists of a statement which assesses feelings of anxiety or relaxation on a 4-point scale ranging from 1 (not at all) to 4 (very much so). Responses to individual items are summed to create an overall score. Scores range from 20 to 80. Higher scores indicate higher levels of anxiety.
measure: Positive and Negative Affect Scale - Positive Affect
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
measure: Positive and Negative Affect Scale - Positive Affect
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
measure: Positive and Negative Affect Scale - Positive Affect
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
measure: Mean R Wave Amplitude
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.
measure: Mean R Wave Amplitude
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.
measure: Mean R Wave Amplitude
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: Mean R wave amplitude was determined via a 3-lead ECG and was measured in millivolts (mV). The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. A total of 5 minutes and 30 seconds of ECG data were collected to allow for artifact trimming. Artifacts were flagged by experimenters during data collection. Mean R wave amplitude represents ventricular depolarization and is measured in millivolts. Higher magnitudes indicated increased polarity associated with an increased force of ventricular contraction.
measure: QT Interval Length
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.
measure: QT Interval Length
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: QTc prolongation was measured in msec and was assessed via 3-lead ECG. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. For detection, typical QRS width was set at 80ms and R waves were at least 300ms apart. QTc was corrected with Bazett's formula. QT interval length represents the length of ventricular depolarization and repolarization and is measured in msec.
measure: QT Interval Length
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: Mean scores and standard deviations were reported as a function of group and time. Single mean imputation was used to impute all missing scores to reflect a sample size of n=60 per condition (N=180 total) based on participants admitted at the beginning of the trial. The outcome analyses were based on imputed values and therefore, overall number of participants analyzed equals 60 per condition in the outcome analyses.
measure: Vagal Cardiac Tone - High Frequency Spectral Power
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.
measure: Vagal Cardiac Tone - High Frequency Spectral Power
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.
measure: Vagal Cardiac Tone - High Frequency Spectral Power
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: High frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG data and was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. ECG data were analyzed via PowerLab LabChart 8 software. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. Increased high frequency spectral power represents increased vagal input to the heart.
measure: Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.
measure: Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.
measure: Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: Low frequency to high frequency spectral power was assessed via heart rate variability (HRV) power spectral analysis of 3-lead ECG. This index was reported in normalized units. The ECG signal was acquired via PowerLab 16/35 psychophysiological data acquisition system with a sampling rate of 1000 Hz. Hardware setup included an ECG100C amplifier with a 35Hz LPN filter and a .5Hz HP filter. Maximum frequency was set at 0.5 Hz with number of frequencies at 500. LF spectral power ranged from 0.04-0.15 Hz. HF spectral power ranged from 0.15-0.45 Hz. The ratio is designed to assess degree of sympathetic innervation to the heart.
measure: Positive and Negative Affect Scale - Negative Affect
time frame: Baseline assessments occurred after screening and prior to the delivery of any interventions.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
measure: Positive and Negative Affect Scale - Negative Affect
time frame: Postintervention assessments were conducted approximately 4 weeks following the baseline assessment.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
measure: Positive and Negative Affect Scale - Negative Affect
time frame: Follow-up assessments began approximately 8 weeks after the postintervention assessment.
description: The Positive and Negative Affect Schedule is a 20-item self-report questionnaire that used to measure positive and negative affect. Items are rated on a 5-point scale ranging from 1 (very slightly) to 5 (extremely) which measures the extent to which the client has experienced that affect over the past week. The 10 positive and 10 negative items are summed separately to create a positive affect score and a negative affect score respectively. Each score ranges between 0 and 50 with higher scores indicating higher positive or negative affect.
arm group label: Educational Brochure
arm group type: Active Comparator
description: Participants will read an educational brochure from the National Eating Disorder Association and will receive referral resources.
arm group label: Body Project Traditional
arm group type: Active Comparator
description: Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project group therapy program (Stice & Shaw, 2001).
arm group label: Body Project Expanded
arm group type: Active Comparator
description: Participants will complete group therapy for 1-hour per week for 4 weeks consisting of the Body Project Expanded group therapy program (Green et al., 2017).
intervention type: Behavioral
intervention name: Educational Brochure
description: Participants will read an educational brochure from the National Eating Disorders Association and will receive treatment referral resources.
arm group label: Educational Brochure
intervention type: Behavioral
intervention name: Body Project Traditional
description: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Traditional group therapy program (see Stice & Shaw, 2001).
arm group label: Body Project Traditional
intervention type: Behavioral
intervention name: Body Project Expanded
description: Participants will complete a 1-hour per week group therapy program for 4 weeks consisting of the Body Project Expanded group therapy program (see Green et al., 2017).
arm group label: Body Project Expanded
criteria: 
gender: Female
minimum age: 15 Years
maximum age: 34 Years
healthy volunteers: No
last name: Melinda A Green, PhD
role: Principal Investigator
affiliation: Green Counseling Services PLLC
facility: 
country: United States
responsible party type: Principal Investigator
investigator affiliation: Cornell College
investigator full name: Dr. Melinda Green
investigator title: Principal Investigator
mesh term: Feeding and Eating Disorders
sharing ipd: Yes
ipd description: Data will be made available to other researchers upon request and subject to signed confidentiality agreement.
ipd info type: Study Protocol
ipd info type: Statistical Analysis Plan (SAP)
ipd info type: Informed Consent Form (ICF)
ipd info type: Clinical Study Report (CSR)
ipd info type: Analytic Code
ipd time frame: Upon request with 5 years of study completion.
ipd access criteria: Must sign confidentiality agreement.
provided document: 
provided document: 
provided document: 
participant flow: 
baseline: 
outcome list: 
reported events: 
certain agreements: 
point of contact: 